JP5433216B2

JP5433216B2 - 台間装置および払出システム

台間装置および払出システム Download PDF

Info

Publication number: JP5433216B2
Authority: JP; Japan
Prior art keywords: payout; inter; type; game; priority
Prior art date: 2008-11-25
Legal status : Active

Application number

JP2008299830A

Other languages

English (en)

Japanese (ja)

Other versions

JP2010124889A (ja

JP2010124889A5 (enExample

Inventor

邦彦春名

省三福永

千絵東

享平岡山

秀治五反田

Current Assignee

Glory Ltd

Original Assignee

Glory Ltd

Priority date

2008-11-25

Filing date

2008-11-25

Publication date

2014-03-05

2008-11-25 Application filed by Glory Ltd filed Critical Glory Ltd

2008-11-25 Priority to JP2008299830A priority Critical patent/JP5433216B2/ja

2010-06-10 Publication of JP2010124889A publication Critical patent/JP2010124889A/ja

2011-11-04 Publication of JP2010124889A5 publication Critical patent/JP2010124889A5/ja

2014-03-05 Application granted granted Critical

2014-03-05 Publication of JP5433216B2 publication Critical patent/JP5433216B2/ja

Status Active legal-status Critical Current

2028-11-25 Anticipated expiration legal-status Critical

Links

238000000034 method Methods 0.000 claims description 41
229960003948 insulin detemir Drugs 0.000 claims description 4
UGOZVNFCFYTPAZ-IOXYNQHNSA-N levemir Chemical compound CCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=2C=CC=CC=2)C(C)C)CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)CSSC[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=C(O)C=C1 UGOZVNFCFYTPAZ-IOXYNQHNSA-N 0.000 claims description 4
230000005540 biological transmission Effects 0.000 claims description 3
238000007726 management method Methods 0.000 description 23
238000004891 communication Methods 0.000 description 7
238000010586 diagram Methods 0.000 description 7
230000000694 effects Effects 0.000 description 4
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
230000006870 function Effects 0.000 description 1
230000010365 information processing Effects 0.000 description 1
NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1